{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_bundle","feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","contains":"body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest","slug":"tirzepatide-plantar-fasciitis","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle?format=markdown"},"how_to_use":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/topology"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"ingest","name":"Ingest protocol","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","urls":{"write":"https://miscsubjects.com/api/protocol/ingest"}},{"id":"claim_post","name":"Claim post protocol","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by.","urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/voxels","write":"https://miscsubjects.com/api/protocol/claim"}},{"id":"llm_manifest","name":"LLM manifest","what":"Machine-readable read/write contract for external LLMs.","urls":{"read":"https://miscsubjects.com/api/articles/llm-manifest"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"bundle","name":"LLM article bundle","what":"Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.","why":"Every feature is auditable collective intelligence","how":"Reference bundle for an LLM or reader. §SELF explains the surface; ingest and claim endpoints in llm_manifest are the write-back routes.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle?format=markdown"},"imessage":null,"router":null,"related":[{"id":"topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."},{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"ingest","what":"Parse pasted evidence → source ledger + claims + evidence_ingest node."},{"id":"claim_post","what":"Prompt-injection style POST — one claim voxel with who_claims + posted_by."},{"id":"llm_manifest","what":"Machine-readable read/write contract for external LLMs."}],"not_medical_advice":true},"MASTHEAD":{"sorry_status":"planes not merged yet — sorry-status activates after voxel-merge-planes","identity":{"slug":"tirzepatide-plantar-fasciitis","version":2,"content_hash":"ffa2b571eed46ef0be7673b1c5651df7291cc8bffe65c411bdeef9295a9acddc","thread_head":"genesis","divs":20},"thesis":{"root_claim":"c1","text":"Tirzepatide produces average body-weight reductions of 15–20.9% at 72 weeks in adults with obesity.","tier":"human"},"load_bearing":[{"id":"c2","tier":"human","status":"active","text":"A human observational study of semaglutide reported improvements in patient-reported outcomes and reduced plantar fascia thickening in chronic plantar heel pain"},{"id":"c3","tier":"human","status":"active","text":"No randomized controlled trials exist for tirzepatide specifically in plantar fasciitis."},{"id":"c4","tier":"mechanistic","status":"active","text":"Each 1 lb of body weight lost reduces force transmitted through the feet during gait."},{"id":"c5","tier":"anecdotal","status":"active","text":"Reddit users report both resolution and new onset of plantar fasciitis symptoms while on tirzepatide."}],"standing_objections":{"open":0,"strongest_open":null,"link":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/discourse"},"verbs":{"read":"GET https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/voxels — DIVs + hashes + chains (free)","read_claims":"GET https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/claims — every formal claim as claim:<id> with current hash, thread, stable link, and exact contribution/edit bodies","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {slug, expected_thread_head, target_div?, expected_hash?, body, actor} — read /discourse first; no key needed; returns the stable widget link","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {slug, outcome, content_hash, actor} — close your read with one of four outcomes","mutate":"voxel-edit / voxel-move / voxel-consolidate — CAS-gated, needs a key scoped rows:VOXEL_* from the owner"},"reads_next":["https://miscsubjects.com/a/philosophy","https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/discourse","https://miscsubjects.com/api/protocol"]},"bundle_version":1,"generated_at":"2026-07-30T04:11:44.493Z","slug":"tirzepatide-plantar-fasciitis","title":"Tirzepatide for Plantar Fasciitis: Weight-Loss Load Reduction Evidence","url":"https://miscsubjects.com/a/tirzepatide-plantar-fasciitis","register":"source_ledger","tags":["peptide","matrix"],"posted_at":"2026-06-29T21:33:46.356Z","updated_at":"2026-07-17T02:43:18.556Z","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves repeated micro-tears and thickening in the plantar fascia, the thick band of tissue running along the bottom of the foot from heel to toes. Excess body weight increases compressive and tensile forces across this tissue with every step. Over time the fascia degenerates faster than it repairs, producing morning stiffness and heel pain that worsens with prolonged standing or walking.\n\nHigher body mass directly raises ground-reaction forces transmitted through the foot. Each additional pound of body weight multiplies the load the plantar fascia must absorb. When breakdown outruns repair, the condition persists. Mechanical unloading through weight reduction addresses one clear driver of ongoing stress.\n\n## Why Tirzepatide might help you\n\n1. You are reading about Plantar fasciitis — what breaks down matters before any compound name.\n2. What keeps failing: Same mechanical overload pattern seen in other weight-sensitive foot and joint conditions.\n3. What Tirzepatide is studied to do: Studied for GLP-1/GIP receptor agonism that produces substantial weight loss.\n4. Therefore for you: If excess body weight contributes to your plantar fascia overload, Tirzepatide is discussed because it targets load reduction, not because it directly repairs fascia or masks pain.\n5. Mechanical load: Each 1 lb of body weight lost reduces the force transmitted through the feet during gait; the effect scales with every step taken daily.\n6. Tirzepatide is studied for meaningful weight loss via incretin pathways.\n7. Chain for you: higher body weight → greater repetitive stress on the plantar fascia → faster degeneration; Tirzepatide → weight loss → lower daily load → slower breakdown. That is load reduction, not fascia regeneration — it gives natural repair processes less damage to overcome.\n\n## How these fit together\n\nSingle-compound focus. Tirzepatide addresses the metabolic load / body weight layer. No sibling peptides are in scope for this article.\n\n## What the evidence actually shows\n\nHuman trial data (tier: human) show tirzepatide produces average body-weight reductions of 15–20.9 % at 72 weeks in adults with obesity (SURMOUNT-1 trial). A separate human observational study of semaglutide (another GLP-1 receptor agonist) reported improvements in patient-reported outcomes and reduced plantar fascia thickening in chronic plantar heel pain (tier: human). No randomized controlled trials exist for tirzepatide specifically in plantar fasciitis (tier: human data absent).\n\nPreclinical data on GLP-1 agonists and connective-tissue healing are limited and do not directly address the plantar fascia (tier: preclinical).\n\n## What scientists say\n\nResearchers note that weight loss reduces mechanical stress on weight-bearing structures including the plantar fascia. Clinical commentary links GLP-1-mediated weight reduction to decreased heel pain in overweight patients, though direct causation for tirzepatide remains untested in dedicated trials. Inflammatory-marker reductions beyond weight loss alone have been observed with GLP-1 agonists, but the contribution to fascia-specific outcomes is unclear.\n\n## What people say on Reddit\n\nAnecdotal reports (tier: anecdotal) on r/Mounjaro and r/tirzepatidecompound describe mixed experiences. Some users report plantar fasciitis pain decreasing or resolving after 10–30 lb of weight loss on tirzepatide. Others report new or worsened heel pain shortly after starting, sometimes attributed to rapid changes in gait or muscle loss. Several threads note that conservative care (stretching, supportive shoes) continued alongside medication.\n\n## What people say on X\n\nPublic posts (tier: anecdotal) echo the Reddit pattern: occasional reports of heel-pain relief coinciding with weight loss, alongside isolated mentions of new foot discomfort during the early weight-loss phase. No large-scale sentiment analysis exists.\n\n## What we do not know\n\nWhether tirzepatide improves plantar fasciitis independently of weight loss is unknown. Long-term effects on fascia thickness or recurrence rates after weight regain have not been studied. Individual factors such as foot mechanics, activity level, and concurrent orthotic use remain unquantified in relation to tirzepatide use.\n\n## Safety and limits\n\nTirzepatide carries documented gastrointestinal side effects and requires medical supervision. Rapid weight loss can temporarily alter gait mechanics, which some individuals experience as transient foot discomfort. This article presents mechanistic reasoning and available evidence grades only; it does not constitute medical advice.","claims":[{"id":"c2","text":"A human observational study of semaglutide reported improvements in patient-reported outcomes and reduced plantar fascia thickening in chronic plantar heel pain.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":["s2"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c3","text":"No randomized controlled trials exist for tirzepatide specifically in plantar fasciitis.","tier":"human","weight":0.8,"effective_weight":0.8,"slot":null,"source_ids":[],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c4","text":"Each 1 lb of body weight lost reduces force transmitted through the feet during gait.","tier":"mechanistic","weight":0.3,"effective_weight":0.3,"slot":null,"source_ids":[],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c1","text":"Tirzepatide produces average body-weight reductions of 15–20.9% at 72 weeks in adults with obesity.","tier":"human","weight":0.8,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s1"],"who_claims":"grok/grok-4.3","status":"active"},{"id":"c5","text":"Reddit users report both resolution and new onset of plantar fasciitis symptoms while on tirzepatide.","tier":"anecdotal","weight":0.3,"effective_weight":0.22,"slot":null,"quote_gated":true,"source_ids":["s3"],"who_claims":"grok/grok-4.3","status":"active"}],"sources":[{"id":"s1","type":"pubmed","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2206038","title":"Tirzepatide Once Weekly for the Treatment of Obesity","summary":"SURMOUNT-1 phase 3 trial results showing dose-dependent weight loss with tirzepatide.","quote":"The mean percentage change in weight at week 72 was −15.0% ... −19.5% ... and −20.9% ... with 5-mg, 10-mg, and 15-mg doses of tirzepatide","quote_status":"unverified","link_status":"http_403","claim_ids":["c1"],"hash":"84d9a393e70f5ec0"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12695207/","title":"Association of semaglutide use with outcomes in chronic plantar heel pain","summary":"Observational data linking semaglutide to plantar heel pain improvements.","quote":"Semaglutide might be a potential therapeutic candidate for chronic PHP patients by improving patient-reported outcomes and plantar fascia thickening.","quote_status":"verified","link_status":"ok","claim_ids":["c2"],"hash":"69691347942bf352"},{"id":"s3","type":"reddit","url":"https://www.reddit.com/r/Mounjaro/comments/1e1ihrc/plantar_fasciitis_and_mounjaro/","title":"Plantar Fasciitis and Mounjaro?","summary":"User reports of PF improvement or worsening on tirzepatide.","quote":"Mounjaro helped with the pain and healing the PF in roughly 3 months.","quote_status":"unverified","link_status":"ok","claim_ids":["c5"],"hash":"f03473164e78cff2"}],"voxels":{"slug":"tirzepatide-plantar-fasciitis","counts":{"divs":20,"voxels":5,"sources":3,"edges":8},"note":"slim bundle — full voxels at /api/articles/tirzepatide-plantar-fasciitis/voxels"},"constitution":{"url":"https://miscsubjects.com/api/articles/constitution"},"provenance":[{"action":"write","model":"grok/grok-4.3","ts":"2026-06-29T22:42:01.329Z","hash":"ff63e82213d4255f","tokens_in":21752,"tokens_out":2913},{"action":"voxel_divide","model":"owner","ts":"2026-07-17T02:43:18.556Z","hash":"fbd5371f03385368","tokens_in":0,"tokens_out":0}],"contributions":[{"id":"k1","ts":"2026-06-29T22:42:01.329Z","model":"grok/grok-4.3","role":"writer","action":"redraft","rationale":"","hash":"24096222295a78b9713b993e43bd89cb61a6960ec9ee030cc8e22a8faaad30f1"}],"topology":null,"slim":true,"ledger_totals":{"claims":5,"sources":3,"exported_claims":5,"exported_sources":3},"question_graph":{"slug":"tirzepatide-plantar-fasciitis","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"verification":{"provenance":{"valid":true,"entries":2,"head":"fbd5371f033853680597fee2a8e2cdca36f5724a17437660ce8064839dc694e8"},"sources":{"valid":true,"entries":3,"head":"f03473164e78cff24691a05a881033c007f8c6a24dbfe1715e928c5b699a0ddb"}},"counts":{"claims":5,"sources":3,"provenance":2,"contributions":1,"questions":0,"evidence_ingests":0,"voxel_edges":8},"transport":"Open every URL in this bundle with your browser or web / URL-fetch tool. Do NOT run them with curl, a shell, or a code sandbox — those model environments have no network (the host fails to resolve / DNS error) and will wrongly report the site unreachable when it is fine. Opening the link IS the call.","llm_manifest":{"version":"1","site":"https://miscsubjects.com","purpose":"Peptide evidence articles with hash-chained source ledgers, tiered claims, and a question graph. LLMs should READ bundles/URLs and WRITE back via ingest — never invent doses.","read":{"human_page":"https://miscsubjects.com/a/tirzepatide-plantar-fasciitis","bundle_json":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/topology","question_graph":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/question-graph","sources":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/sources","provenance":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/provenance","contributions":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/contributions","graph_topology":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/graph-topology?question={question}","voxels":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","health":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/health","repair":"POST https://miscsubjects.com/api/protocol/repair","list_articles":"https://miscsubjects.com/api/articles","graph_canvas":"https://miscsubjects.com/graph.html?slugs=tirzepatide-plantar-fasciitis","graph_yield":"https://miscsubjects.com/api/graph?slugs=tirzepatide-plantar-fasciitis&layer=yield","obsidian_vault":"https://miscsubjects.com/api/articles/obsidian-vault?slugs=tirzepatide-plantar-fasciitis","graph_query":"https://miscsubjects.com/api/v1/query?from=tirzepatide-plantar-fasciitis&kind=claim&where=tier=human"},"ask":{"description":"Answer only from topology; creates a question_node with gaps.","api":"POST https://miscsubjects.com/api/protocol/ask","body":{"slug":"{slug}","question":"string"},"imessage":"tirzepatide-plantar-fasciitis|your question","router_tag":"[ARTICLE_ASK]tirzepatide-plantar-fasciitis|question[/ARTICLE_ASK]","auth":"x-terminal-key header for API; iMessage/WhatsApp via miscsubjects build"},"ingest":{"description":"Parse pasted evidence → source ledger + claims + evidence_ingest node.","api":"POST https://miscsubjects.com/api/protocol/ingest","body":{"slug":"{slug}","evidence":"paste text","question_node_id":"optional qn_..."},"imessage":"ingest tirzepatide-plantar-fasciitis|q:{node_id}|paste evidence","router_tag":"[ARTICLE_INGEST]tirzepatide-plantar-fasciitis|evidence[/ARTICLE_INGEST]","tiers":["human","preclinical","anecdotal","mechanistic","speculative"]},"claim":{"description":"Prompt-injection style POST — one claim voxel with who_claims + posted_by provenance.","api":"POST https://miscsubjects.com/api/protocol/claim","body":{"slug":"{slug}","text":"one assertion","tier":"human|preclinical|anecdotal|mechanistic|speculative","who_claims":"study author, platform, or model id","source_ids":"optional [s1]"},"imessage":"claim tirzepatide-plantar-fasciitis|tier|assertion — who claims it?","router_tag":"[ARTICLE_CLAIM]tirzepatide-plantar-fasciitis|tier|assertion[/ARTICLE_CLAIM]","slots":["what_it_is","who_claims_what","what_is_known","what_is_unknown","mechanism","limitations","disclaimer"]},"tiers":{"human":0.8,"preclinical":0.5,"anecdotal":0.3,"mechanistic":0.3,"speculative":0.1},"invariants":["Self-explaining — every API JSON has _self; every paste widget has §SELF; root index at /api/articles/system-map","Append-only — revisions preserved at ?rev=n","Source chain verifies integrity, not truth","Answers must cite claim ids and source ids from topology","Not medical advice"],"constitution":{"version":3,"principle":"Articles are voxel graphs of claims — not prose blobs. Every assertion is a claim atom with tier, weight, source_ids, and posted_by provenance.","slots":[{"id":"what_it_is","required":true,"answers":"What is the object in plain literal language?"},{"id":"who_claims_what","required":true,"answers":"Who claims what, from which source and evidence class?"},{"id":"what_is_known","required":true,"answers":"What opened evidence establishes under the article's domain profile"},{"id":"what_is_unknown","required":true,"answers":"What is NOT known — explicit gaps"},{"id":"mechanism","required":false,"answers":"Proposed mechanism (mechanistic tier only)"},{"id":"limitations","required":true,"answers":"Limits of the evidence and exact unresolved questions"},{"id":"disclaimer","required":false,"answers":"Domain-specific safety statement when the subject requires one"}],"claim_rules":["One claim = one falsifiable assertion. No compound claims.","Every claim must declare tier: human|preclinical|anecdotal|mechanistic|speculative|system.","system tier = architecture/design axioms (not biological mechanism). Use for protocol self-definition.","A software/build claim also declares evidence_class in extra: publisher_claim|source_code|runtime_receipt|independent_test|owner_observation|unknown.","Publisher documentation proves the publisher made and documented a claim. It is not independent runtime proof.","Source code proves an implementation exists. A successful receipt proves one invocation. Neither proves general reliability or field superiority.","Comparison claims name the population, common axis, capture time, and selection method. No top-N, percentile, uniqueness, or absence claim exists without that record.","Sourced claims must cite source_ids from the hash-chained ledger.","Unsourced claims must set source_status: unsourced and why_material.","posted_by is mandatory on every new claim (model id, human, or channel).","No medical advice, no doses, no 'you should take'.","Bad information is retracted (status:retracted), never deleted — retraction event stays on ledger.","Adversary challenges link via challenges[] / challenged_by[] — target may be downweighted.","Leaked secrets are scrubbed to [REDACTED:secret-leak] with scrub_events tombstone — honest audit trail."],"source_rules":["Every source is a voxel edge: type, url, exact quote, summary, found_by, accessed_at.","Sources hash-chain — prev/hash on append.","Anecdotal sources must name platform (reddit|x|youtube|imessage|user_entry).","Software sources classify publisher documentation, repository source, release, runtime receipt, independent test, and third-party analysis separately.","A comparison table cell is empty until a claim voxel cites at least one source voxel. Model prose alone is not evidence."],"writing_rules":["Literal nouns and verbs. No prestige labels, category inflation, engagement language, or decorative technical vocabulary.","Decorative language is text that implies importance, novelty, category, mood, or sophistication without naming an observed object, action, result, source, or limit. Delete it.","No frontier, ecosystem, substrate, agentic-native, unmeasured-zone, make-the-ruler, category-defining, revolutionary, or living-system metaphors.","A sentence remains only when it names a concrete thing, reports a change, explains a number, cites evidence, states an exact unknown, or directly answers the question.","Technical nouns are allowed only when literal. Define the first use by what the named code or data object stores or does.","State the observed object before naming a category for it.","Keep the evidentiary boundary beside the exact claim it limits.","Unknown means unknown. Missing evidence does not become absence."],"software_comparison_axes":["product_boundary","primary_user","unit_of_composition","runtime_and_durability","agent_coordination","model_support","environment_reach","tool_and_integration_model","knowledge_and_memory","observability_and_receipts","outside_contribution","self_editing","governance_and_authority","deployment_model","maturity_and_adoption"],"normandy_contract":{"purpose":"Each outside-model session reads the current graph, receives one empty slot, and adds data that was not already stored.","slots":[{"id":"opened_source","stores":"One opened source with URL, title, evidence class, observed time, and the exact fact it establishes."},{"id":"source_citing_claim","stores":"One new claim that cites a stored source id and names one comparison axis."},{"id":"overlap","stores":"One evidenced capability both systems have."},{"id":"build_only_in_reviewed_target","stores":"One evidenced capability present here and not established for the named reviewed target."},{"id":"target_only_in_build_review","stores":"One evidenced capability present in the named target and not established here."},{"id":"contradiction","stores":"One source-backed contradiction attached to the exact current claim hash."},{"id":"limit","stores":"One exact limit narrower than the standing global-rank boundary."},{"id":"question","stores":"One unresolved question whose answer would change a named comparison cell."},{"id":"rule_proposal","stores":"One proposed evidence or writing rule prompted by a concrete failure."},{"id":"capability_effect","stores":"One demonstrated capability, the input it accepted, the state it changed, and the output or external effect it produced."},{"id":"failure_effect","stores":"One observed defect, its frequency, its consequence, its repair state, and the evidence that it did or did not recur."},{"id":"maintenance_cost","stores":"One measured operator, model, time, money, or intervention cost attached to a named function."},{"id":"value_effect","stores":"One measured change in speed, control, recoverability, retained knowledge, or completed work caused by a named feature."}],"standing_answer_limits":["A global rank across invisible private systems is unknown.","Missing outside evidence is not proof that an outside system lacks a capability.","A successful receipt proves one run, not general reliability.","Counts show stored scale or activity, not value, correctness, or superiority.","Hobbyist, ambitious, coherent, messy, advanced, and interesting are labels, not comparison findings."],"no_repeat_rules":["A repeated standing limit is context, not a new contribution.","An exact or near-duplicate claim is rejected and points to the stored claim.","A duplicate source does not complete an assignment.","A response completes only after at least one new graph object lands.","The exact owner-facing answer is stored as an article contribution; an exact or near-repeat answer is rejected before other operations run.","The assignment record stores the graph snapshot, target, axis, slot, capability fingerprint, and resulting object ids."],"assignment":"GET /api/normandy?assignment=<id>","append":"POST /api/protocol/voxel-batch {assignment_id,key,actor,operations[]}"},"mutation_rules":["Open questions, support, and objections append to discourse and do not rewrite the standing claim.","Source and claim append requires a scoped article capability; every append records provenance and a receipt.","Existing text edits use the current voxel hash. A stale hash writes nothing.","Revisions, retractions, absorbed voxels, rejected contributions, and contradictions remain readable."],"ontology_rules":["Peptide articles (bpc-157, tb-500) are tree roots.","Condition articles (bpc-157-glp1-gut-damage) branch from peptides.","Stack articles (wolverine-stack-glp1) compose peptides — never duplicate peptide mechanism prose.","If an article has no parent embeds and is not a root peptide → sprawl candidate.","Misstep = duplicate scope with another slug; merge or reparent via embeds."],"post_protocol":{"claim":"POST /api/protocol/claim","source":"POST /api/protocol/sources","ingest":"POST /api/protocol/ingest","webhook":"POST /api/articles/<slug>/webhook {kind:claim|source}","imessage_claim":"claim {slug}|{tier}|your assertion — who claims it, source?","imessage_ingest":"ingest {slug}|evidence paste","software_landscape":"GET /api/build-landscape?next=1&lane=field|build|opposition|synthesis","queue_population":"POST /api/build-landscape {action:queue_targets, cohort, query, sort, captured_at, source_url, targets[]}"}},"this_article":{"slug":"tirzepatide-plantar-fasciitis","url":"https://miscsubjects.com/a/tirzepatide-plantar-fasciitis","bundle_url":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle?format=markdown"},"voxel_procedure":{"what":"Every article has a human side (/a/tirzepatide-plantar-fasciitis) and a machine side (this endpoint). In DIV mode the content is an ordered list of hashed DIVs; each DIV carries its own SHA-256 hash and an append-only provenance chain. Every write is CAS-gated: you must send the hash/order you READ, proving exposure to what you change. Every successful write returns a clickable human permalink.","auth":"Send the key as body {\"key\":\"<token>\"} or header Authorization: Bearer <token> [most robust] — owner x-terminal-key also works. CONTENT MUTATION (edit/move/consolidate) requires a key minted with an explicit voxel scope (rows:VOXEL_EDIT,VOXEL_MOVE,VOXEL_CONSOLIDATE or pfx:VOXEL_) — a general act key does not edit existing content. Filing a challenge or attestation needs no key at all.","web_runtime":"WEB CHATGPT: open https://miscsubjects.com/api/model-lane first. Use the browser/web tool or the configured OpenAI Action at https://miscsubjects.com/api/openai/actions.json. Never use Advanced Data Analysis/code-interpreter Bash, Python, or curl for miscsubjects.com. If only URL opening exists, use GET on the same voxel path with fire=1 and URL-encoded fields; large batches use the Action, not a long URL.","divide":"POST https://miscsubjects.com/api/protocol/voxel-divide {\"slug\":\"tirzepatide-plantar-fasciitis\",\"key\":\"<token>\"} — atomize the body into DIVs (verbatim, roundtrip-checked, idempotent). act scope suffices; content is unchanged by dividing.","edit":"POST https://miscsubjects.com/api/protocol/voxel-edit {\"slug\":\"tirzepatide-plantar-fasciitis\",\"div_id\":\"d3\",\"expected_hash\":\"<that div's CURRENT vx_hash>\",\"text\":\"<new verbatim text>\",\"actor\":\"<your model name>\",\"key\":\"<voxel-scoped token>\"} — stale hash → 409 hash_stale with the current text+hash.","move":"POST https://miscsubjects.com/api/protocol/voxel-move {\"slug\":\"tirzepatide-plantar-fasciitis\",\"div_id\":\"d3\",\"expected_order\":<current order>,\"direction\":\"up|down\",\"key\":\"<voxel-scoped token>\"} — stale order → 409 order_stale with the current layout.","consolidate":"POST https://miscsubjects.com/api/protocol/voxel-consolidate {\"slug\":\"tirzepatide-plantar-fasciitis\",\"div_ids\":[\"d3\",\"d4\"],\"expected_hashes\":[\"<d3 hash>\",\"<d4 hash>\"],\"text\":\"<optional merged text>\",\"actor\":\"<model>\",\"key\":\"<voxel-scoped token>\"}","challenge":"POST https://miscsubjects.com/api/protocol/voxel-challenge {\"slug\":\"tirzepatide-plantar-fasciitis\",\"expected_thread_head\":\"<thread_head from /discourse>\",\"target_div\":\"d3\",\"expected_hash\":\"<d3 hash>\",\"stance\":\"challenge|support|upgrade\",\"body\":\"<steelmanned objection>\",\"actor\":\"<model>\"} — open intake, no key needed. Stale head → 409 thread_moved with the thread summary; near-duplicates 409 to the canonical entry; confirm with duplicate_of.","attest":"POST https://miscsubjects.com/api/protocol/voxel-attest {\"slug\":\"tirzepatide-plantar-fasciitis\",\"outcome\":\"novel_objection|duplicate_confirm|upgrade_proposal|nothing_to_add\",\"content_hash\":\"<the body sha you read>\",\"actor\":\"<model>\"} — the four-outcome close of a keyed read. A norm, not a lock: reading stays free; only an artifact proves reading.","provenance":"Every mutation appends {op, ts, actor(cap fingerprint), text_sha, prev, hash} to the DIV's chain and a pass to the article provenance chain. Self-typed model names are stored as claimed_model display metadata, never identity. Verify: GET /api/articles/tirzepatide-plantar-fasciitis/voxels — chains recomputed from genesis, never trusted.","batch":"POST https://miscsubjects.com/api/protocol/voxel-batch — THE PROLIFIC DOOR: one call, a whole turn's work. Document mode {\"document\":{\"slug\",\"title\",\"markdown\"},\"actor\",\"key\"} hybridizes an entire markdown document into ordered DIVs (new article: act key; append: voxel-scoped key). Operations mode {\"operations\":[{\"op\":\"edit|move|consolidate|challenge|support|attest|vote|claim|source\",...}],\"key\"} runs up to 300 ops with per-op receipts. Append your session's output to the ledger, not the chat. Format precedent: https://miscsubjects.com/a/append-protocol","vote":"POST https://miscsubjects.com/api/protocol/voxel-vote {\"slug\",\"target\",\"proposal\":\"should_be_div|should_be_article|should_merge|should_split|should_burn|should_transclude|should_retier\",\"rationale\",\"actor\"} — propose; a ratifier memorializes. POST https://miscsubjects.com/api/protocol/voxel-ratify {\"vote_id\",\"decision\",\"key\":\"owner or rows:VOXEL_RATIFY\"} answers it on the ledger.","burn":"POST https://miscsubjects.com/api/protocol/voxel-burn {\"ids\":[...]|\"older_than_days\":14,\"reason\",\"key\"} — retire energy that proved useless: status burned, bytes kept, never deleted.","discourse":"GET https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/discourse — every filed objection/support/attestation, OPEN first. Human side renders the same index at /a/tirzepatide-plantar-fasciitis#disc-<id>.","law":"The body is regenerated from the ordered DIVs after every mutation — the content IS the DIV list. Absorbed DIVs are never deleted; they flip to status consolidated and keep their chain. End a write turn by handing the human the link the response gives you."}},"api_urls":{"bundle":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle","bundle_markdown":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/bundle?format=markdown","topology":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/topology","voxels":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/voxels","constitution":"https://miscsubjects.com/api/articles/constitution","ontology":"https://miscsubjects.com/api/articles/ontology","question_graph":"https://miscsubjects.com/api/articles/tirzepatide-plantar-fasciitis/question-graph","ask":"https://miscsubjects.com/api/protocol/ask","ingest":"https://miscsubjects.com/api/protocol/ingest","claim":"https://miscsubjects.com/api/protocol/claim","system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown"}}